XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net income (loss) $ 17,732,000 $ (131,339,000)
Adjustments to reconcile net income (loss) to cash flow provided by (used in) operating activities:    
Gain on sale of hotel properties, net (1,053,000) (1,186,000)
Loss on extinguishment of indebtedness, net 0 6,207,000
Depreciation and amortization 93,787,000 93,858,000
Amortization of deferred financing costs 3,101,000 2,685,000
Other amortization 1,136,000 (1,177,000)
Reclassification of unrealized (gains) losses on discontinued cash flow hedges to other income (expense), net (5,866,000) 10,658,000
Equity in (income) loss from unconsolidated joint ventures (405,000) 238,000
Impairment losses 0 5,946,000
Amortization of share-based compensation 10,654,000 7,600,000
Changes in assets and liabilities:    
Hotel and other receivables, net (10,018,000) (12,071,000)
Prepaid expense and other assets 1,450,000 1,969,000
Accounts payable and other liabilities 7,680,000 2,058,000
Advance deposits and deferred revenue (1,401,000) (9,399,000)
Accrued interest (493,000) (66,000)
Net cash flow provided by (used in) operating activities 116,304,000 (24,019,000)
Cash flows from investing activities    
Proceeds from sales of hotel properties, net 48,073,000 16,268,000
Improvements and additions to hotel properties (51,406,000) (25,087,000)
Purchase deposits (1,500,000) (1,500,000)
Contributions to unconsolidated joint ventures 0 (331,000)
Net cash flow used in investing activities (4,833,000) (10,650,000)
Cash flows from financing activities    
Repayment of Revolver (200,000,000) (200,000,000)
Proceeds from issuance of $500.0 million senior notes due 2026 0 500,000,000
Scheduled mortgage loan principal payments 0 (1,488,000)
Repayments of Term Loans 0 (356,338,000)
Repayments of mortgage loans 0 (120,469,000)
Repurchase of common shares under a share repurchase program (47,446,000) 0
Repurchase of common shares to satisfy employee tax withholding requirements (3,589,000) (2,075,000)
Distributions on preferred shares (12,557,000) (12,557,000)
Distributions on common shares (3,522,000) (3,369,000)
Distributions on Operating Partnership units (10,000) (10,000)
Payments of deferred financing costs (10,000) (7,670,000)
Contributions from consolidated joint venture partners 156,000 589,000
Distribution to consolidated joint venture partners (2,600,000) 0
Net cash flow used in financing activities (269,578,000) (203,387,000)
Net change in cash, cash equivalents, and restricted cash reserves (158,107,000) (238,056,000)
Cash, cash equivalents, and restricted cash reserves, beginning of year 713,869,000 934,790,000
Cash, cash equivalents, and restricted cash reserves, end of period $ 555,762,000 $ 696,734,000